| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9343(99)80188-0 |
| P698 | PubMed publication ID | 7573096 |
| P50 | author | Graham R. V. Hughes | Q73300356 |
| Munther A. Khamashta | Q73418907 | ||
| P2093 | author name string | E Toubi | |
| A Panarra | |||
| P2860 | cites work | Thrombosis, abortion, cerebral disease, and the lupus anticoagulant | Q24675412 |
| Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy | Q28273764 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Anticardiolipin antibodies: isotype distribution and phospholipid specificity | Q33456927 | ||
| Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease | Q33490122 | ||
| Rheumatic disease in Jamaica | Q33551951 | ||
| Attributing psychopathology to systemic lupus erythematosus: some methodological considerations | Q35898100 | ||
| The antiphospholipid syndrome: ten years on. | Q40711282 | ||
| Psychiatric disorder and cognitive impairment in systemic lupus erythematosus | Q41120214 | ||
| Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome | Q41238775 | ||
| Non-organic non-psychotic psychopathology (NONPP) in patients with systemic lupus erythematosus | Q41924726 | ||
| Central nervous system disease in patients with systemic lupus erythematosus | Q43900011 | ||
| Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus | Q46909297 | ||
| Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. | Q48144813 | ||
| Magnetic resonance imaging of human cerebral infarction: enhancement with Gd-DTPA. | Q48239691 | ||
| Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus | Q48423132 | ||
| Membranous and vascular choroidopathy: two patterns of immune deposits in systemic lupus erythematosus | Q48709487 | ||
| Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers | Q48752879 | ||
| Positron emission tomography in neuropsychiatric lupus erythematosus | Q49124199 | ||
| The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. | Q51236322 | ||
| Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study | Q67925068 | ||
| Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III | Q68755816 | ||
| Neurological disease associated with antiphospholipid antibodies | Q69624901 | ||
| The neurological manifestations of systemic lupus erythematosus | Q70861096 | ||
| P433 | issue | 4 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| central nervous system disease | Q5062122 | ||
| nervous system | Q9404 | ||
| P304 | page(s) | 397-401 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus | |
| P478 | volume | 99 |
| Q28192380 | Antiphospholipid antibodies in young adults with stroke |
| Q35134524 | Arterial thromboembolism in pregnancy |
| Q34896821 | Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus |
| Q58766114 | Audiovestibular Symptoms in Systemic Autoimmune Diseases |
| Q36332517 | Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus |
| Q35129275 | Behavioral heterogeneity in an animal model of neuropsychiatric lupus. |
| Q35811587 | Chorea as a first manifestation in young patients with systemic lupus erythematosus who was initially diagnosed with rheumatic Fever |
| Q33750289 | Disorders that mimic central nervous system infections |
| Q47665064 | Frequency of anticardiolipin, antinuclear and anti beta2GP1 antibodies is not increased in unselected epileptic patients: a case-control study. |
| Q74456594 | Hughes (antiphospholipid) syndrome. Clinical features |
| Q35550296 | Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus |
| Q34499518 | Lupus vasculitis: differential diagnosis with antiphospholipid syndrome |
| Q37270276 | Mania: psychiatric manifestations of the antiphospholipid syndrome |
| Q80335294 | Neurologic manifestations of the antiphospholipid syndrome |
| Q34317751 | Neurologic manifestations of the antiphospholipid syndrome. |
| Q33499900 | Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model |
| Q73239513 | Neuropsychiatric Systemic Lupus Erythematosus |
| Q59924786 | Neuropsychiatric systemic lupus erythematosus |
| Q33574487 | Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations |
| Q36270159 | Pattern of MRI brain in neuro-psychiatric SLE. Effect of anti-phospholipid antibodies: A study at a tertiary care teaching hospital |
| Q84594208 | Predictors for neuropsychiatric development in Chinese adolescents with systemic lupus erythematosus |
| Q73251573 | Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus |
| Q50944728 | Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. |
| Q37281860 | Primary antiphospholipid antibody syndrome: neuroradiologic findings in 11 patients |
| Q48301096 | Psychosis leading to the diagnosis of unrecognized systemic lupus erythematosus: a case report |
| Q35549623 | Retinal disease in patients with systemic lupus erythematosus |
| Q41605531 | Role of autoantibody tests in the diagnostic evaluation of neuropsychiatric systemic lupus erythematosus. |
| Q37040824 | Role of brain inflammation in epileptogenesis |
| Q31129756 | Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV). |
| Q33374004 | Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis |
| Q73737431 | Spastic quadriparesis: an unusual early manifestation of systemic lupus erythematosus |
| Q79245668 | Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy |
| Q36015898 | Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature |
| Q77467515 | [Neurological manifestations of antiphospholipid syndrome] |
Search more.